FIELD: pharmaceutics.
SUBSTANCE: invention relates to a compound of formula (I') or an optical isomer, a geometric isomer, a deuterated derivative or a pharmaceutically acceptable salt thereof, which have inhibitory activity on ATM kinase. Values of substitutes Y, R4, R5, R6, R7, L, A, W, h, t1 and t2 in formula (I') are given in the claim. Invention also relates to specific compounds of formula (I'), a pharmaceutical composition containing said compounds, use thereof to produce an ATM kinase inhibitor and a drug for preventing and/or treating a disease at least partially mediated by ATM kinase, their use in combination with an anticancer agent for treating cancer, methods for preparing them and intermediate compounds.
EFFECT: class of condensed ring compounds and their production and use are disclosed.
31 cl, 15 tbl, 117 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | 2011 |
|
RU2623427C2 |
| SULFONIMIDAMIDE COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY | 2019 |
|
RU2820289C2 |
| BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
| BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
| BENZOXEPIN PI3 INHIBITORS AND METHODS FOR USING THEM | 2010 |
|
RU2557658C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN MEDICINAL PREPARATIONS | 2014 |
|
RU2694254C1 |
| HETEROCYCLIC COMPOUNDS AS TRK INHIBITORS | 2019 |
|
RU2803817C2 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| HETEROCYCLIC COMPOUND OF PYRIMIDIN-4(3H)-ONE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2021 |
|
RU2839367C1 |
| NOVEL ANTHELMINTIC COMPOUNDS | 2019 |
|
RU2828007C2 |
